PRKAA2 and Alzheimer disease: Although this AMPK/Sp1/ACSL4 signalling has been implicated in models of cancer (Zhang et al., 2019; Liu et al., 2020; Liu et al., 2024), it remains unexplored in AD-associated ferroptosis.